Spiperone
From Wikipedia, the free encyclopedia
 |
|
|
Spiperone
|
|
| Systematic (IUPAC) name | |
| 8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl- 1,3,8-triazaspiro[4.5]decan-4-one |
|
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C23H26FN3O2 |
| Mol. mass | 395.47 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Spiperone (also known as Spiroperidol, Spiropitan) is a drug which is a butyrophenone derivative. It acts on subsets of both 5-HT receptors and dopamine receptors, and is used to treat schizophrenia.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
